CN113662528B - Quantum detection therapeutic instrument and quantum resonance analysis method - Google Patents
Quantum detection therapeutic instrument and quantum resonance analysis method Download PDFInfo
- Publication number
- CN113662528B CN113662528B CN202110974731.6A CN202110974731A CN113662528B CN 113662528 B CN113662528 B CN 113662528B CN 202110974731 A CN202110974731 A CN 202110974731A CN 113662528 B CN113662528 B CN 113662528B
- Authority
- CN
- China
- Prior art keywords
- detection
- quantum
- signals
- liquid medicine
- human body
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
- A61B5/00—Measuring for diagnostic purposes; Identification of persons
- A61B5/05—Detecting, measuring or recording for diagnosis by means of electric currents or magnetic fields; Measuring using microwaves or radio waves
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Radiology & Medical Imaging (AREA)
- Biophysics (AREA)
- Pathology (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Heart & Thoracic Surgery (AREA)
- Medical Informatics (AREA)
- Physics & Mathematics (AREA)
- Surgery (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Measurement And Recording Of Electrical Phenomena And Electrical Characteristics Of The Living Body (AREA)
Abstract
The invention discloses a quantum detection therapeutic instrument and a quantum resonance analysis method, wherein the quantum detection therapeutic instrument comprises: the tester comprises a tester body, a drug detection tray, a test probe and a handheld electrode; the tester body comprises an anode, a cathode, a display screen, a singlechip processing module and a giant magnetoresistance sensing circuit; the giant magnetoresistance sensing circuit is used for preprocessing a signal detected by the test probe and outputting the signal as a voltage signal; the single chip microcomputer processing module is used for carrying out resonance action on signals output by the giant magneto-resistance sensing circuit and standard detection waveform codes of standard magnetic field waves corresponding to detection items, analyzing resonance signals and obtaining quantized values corresponding to the detection items based on three vectors of an electric field, a magnetic field and a force field and Fourier mathematical conversion.
Description
Technical Field
The invention relates to the technical field of quantum resonance, in particular to a quantum detection therapeutic instrument and a quantum resonance analysis method.
Background
The development of quantum medicine has evolved from the combination of quantum physics and life sciences. All organisms and substances have extremely weak magnetic fields, the magnetic fields are generated by the rotation of electrons around nuclei, and the weak magnetic fields in the substances of the organisms are captured and analyzed by a quantum resonance detector, so that the purposes of disease diagnosis and treatment are achieved. The technology for diagnosing and treating diseases by using a quantum resonance detector in clinical medicine is called quantum medicine Igl. The quantum medicine can measure the state of the ultra-fine field of the human body, so that the method can provide conditioning guidance for the patient in advance, and has great breakthrough and contribution in preventive medicine.
The human body is a 'charged body', each organ is a 'charged body', each cell is a 'charged body', potential difference exists between the inside and outside of a cell membrane, any metabolic activity of the cell can cause potential change, extremely weak current is generated, and according to an electrical principle, an electric field, a magnetic field and a force field are mutually connected systems, and all the activities of the cell can emit weak electromagnetic waves. The quantum resonance detector is to take signals from cells, organs, etc. of human body, and to detect the body and heart state of human body through computer analysis and comparison by means of three-dimensional Fourier digital conversion of electric field, magnetic field and force field and 16 parameters. At present, the time for introducing the quantum resonance technology in China is too short, the technology is still not mature, and related research work is continuously carried out.
Disclosure of Invention
In order to solve the above technical problems, the present invention provides a quantum detection therapeutic apparatus, including: the tester comprises a tester body, a test probe and a handheld electrode; the tester body comprises an anode, a cathode, a display screen, a singlechip processing module and a giant magnetoresistance sensing circuit;
direct current is applied between the positive electrode and the negative electrode, and the test probe is connected with the positive electrode of the tester body; the handheld electrode is detachably connected with the negative electrode of the tester body;
the giant magnetoresistance sensing circuit is used for preprocessing the signals detected by the test probes and outputting the signals as voltage signals;
the singlechip processing module is used for carrying out resonance action on the signal output by the giant magnetoresistance sensing circuit and a standard detection waveform code of a standard magnetic field wave corresponding to a detection item, analyzing a resonance signal, and obtaining a quantized value corresponding to the detection item based on three vectors of an electric field, a magnetic field and a force field and Fourier mathematical conversion;
the display screen displays the quantized values, the reading of the quantized values consists of two values, namely an initial reading and a falling point ID, wherein if the initial value is lower than a first threshold value and the falling point ID is larger than O, the abnormal detection data is represented, and if the initial value is lower than a second threshold value and the falling point ID is larger than O, the serious abnormal detection data is represented.
Further, the quantum detection therapeutic apparatus also comprises a medicine detection tray for holding medicine liquid for soaking the cell tissues to be detected; the medicine detection tray or the handheld electrode is detachably connected with the negative electrode of the tester body respectively.
Further, the giant magnetoresistance sensing circuit utilizes 4 giant magnetoresistance to form a wheatstone bridge, R2 and R3 are used as sensing resistors, and R1 and R4 are used as reference resistors.
Further, a direct current of 1V was applied between the positive electrode and the negative electrode.
Further, the singlechip processing module carries out cross-correlation processing on detection signals of liquid medicine detection and human body detection.
Further, the test probe is wrapped by an insulating layer, and the inner contact is made of brass or silver; the handheld electrode is of a tubular structure made of brass.
The invention also provides a quantum resonance analysis method by using the quantum detection therapeutic apparatus, when the human body is detected, the handheld electrode is connected to the negative electrode of the tester body, the handheld electrode is held by the hand of the detected person, and the detected point of the detected person is pressed by the top metal head of the test probe, so that a loop is formed between the quantum detection therapeutic apparatus and the detected person;
inputting human body detection signals acquired by the test probes into the giant magneto-resistance sensing circuit, converting the human body detection signals into voltage signals and outputting the voltage signals to the singlechip processing module;
in the single chip microcomputer processing module, the signal output by the giant magneto-resistance sensing circuit and the standard detection waveform code of the standard magnetic field wave corresponding to the detection item are subjected to resonance action, resonance signals are analyzed, and quantized values corresponding to the detection item are obtained based on three-vector and Fourier mathematical conversion of an electric field, a magnetic field and a force field.
Further, when the liquid medicine is detected, the medicine detection tray is connected to the negative electrode of the tester body, and the metal head at the top end of the test probe is used for contacting the detected point of the liquid medicine, so that a loop is formed between the quantum detection therapeutic instrument and the medicine detection tray; and inputting the liquid medicine detection signals acquired through the test probes into the giant magneto-resistance sensing circuit, converting the liquid medicine detection signals into voltage signals and outputting the voltage signals to the singlechip processing module.
Further, the liquid medicine detection and the human body detection are respectively carried out through the quantum detection therapeutic instrument, and the two detection signals are subjected to cross-correlation treatment, specifically:
the human body detection signal is x (n), the liquid medicine detection signal is y (n), and the cross correlation function r xy (m) is defined as follows:
cross correlation function r xy (m) reflects the similarity between the liquid medicine detection signal y (n) and the human body detection signal x (n) after shifting left by m sampling intervals, the greater the similarity is, the higher the accuracy of the detection result is, the smaller the similarity is, and the lower the accuracy of the detection result is.
Further, when the human body detection signal x (n) and the liquid medicine detection signal y (n) have no similarity, the cross-correlation function r xy The value of (m) is zero.
Drawings
FIG. 1 is a schematic diagram of a quantum detection therapeutic apparatus according to the present invention;
fig. 2 is a schematic diagram of the internal structure of the giant magnetoresistance sensing circuit of the quantum detection therapeutic apparatus according to the present invention.
Detailed Description
The following description of the embodiments of the present invention will be made clearly and completely with reference to the accompanying drawings, in which it is apparent that the embodiments described are only some embodiments of the present invention, but not all embodiments. All other embodiments, which can be made by those skilled in the art based on the embodiments of the invention without making any inventive effort, are intended to be within the scope of the invention.
As shown in fig. 1, the quantum detection therapeutic apparatus of the present invention comprises: the tester comprises a tester body, a medicine detection tray, a test probe and a handheld electrode.
The method is characterized in that 1V direct current is added between two electrodes of the quantum detection therapeutic instrument, electrons and ions flow through a person or liquid medicine to be detected under the action of the current, the movement of the electrons can cause the change of magnetic field energy generated in the person or the liquid medicine, and weak electromagnetic waves fed back by the human body or the liquid medicine are detected through a test probe and a handheld electrode.
The test probe is wrapped by an insulating layer, and the inner contact is made of brass or silver and is connected with the positive electrode of the tester body. The handheld electrode is a tubular structure made of brass, and a tester holds the insulating outer layer of the test probe by hand and then presses the tested point of the tester with the top metal head of the test probe. The negative electrode of the tester body is connected with the handheld electrode, and the handheld electrode is held by a person to be tested in the testing process, so that a loop is formed between the quantum detection therapeutic instrument and the person to be tested. In the detection, the subject is required to be kept in a relaxed state without carrying any metal or magnetic substance. The detection points are flexibly selected, and in principle all parts of the body can be selected, and hands or feet are usually selected for convenience. The single detection time is about one minute.
The tester body comprises a display screen, a singlechip processing module and a giant magnetoresistance sensing circuit; because electromagnetic waves fed back by human bodies or liquid medicine belong to weak magnetic fields, signals detected by the test probes need to be preprocessed by the giant magneto-resistance sensing circuit.
Giant magnetoresistance sensing circuit: the wheatstone bridge is composed of 4 giant magnetoresistance, and the internal structure is shown in fig. 2: wherein R2 and R3 are used as sensing resistors, and R1 and R4 are used as reference resistors. D1 represents the length of the interval between the two magnetic field concentration areas, and D2 represents the length of the magnetic field concentration area. The two sense resistors R2, R3 are placed in the middle of the gap between the two magnetic field concentration areas, and the reference resistors R1, R4 are sealed inside the magnetic field concentration areas so that the resistance value isolated from the external magnetic field is not changed due to the change of the external magnetic field. Since the 4 giant magneto resistors are all made of the same material, the temperature coefficient and other characteristics are the same, and the temperature drift is small. When an external magnetic field is applied, the resistance values of the two sensing resistors R2 and R3 change along with the change of the external magnetic field, while the resistance values of the reference resistors R1 and R4 are unchanged, so that the bridge imbalance converts a magnetic field signal into a voltage signal and outputs the voltage signal.
The single chip microcomputer processing module is used for carrying out resonance action on the voltage signal output by the giant magneto-resistance sensing circuit and the standard detection waveform code of the standard magnetic field wave corresponding to the detection item, if the output accurate magnetic field signal is similar to the stored standard detection waveform code, a resonance signal is generated, otherwise, a non-resonance signal is generated; and analyzing the resonance signals, and obtaining a quantized value corresponding to the detection item based on three-vector of an electric field, a magnetic field and a force field and Fourier mathematical conversion.
The display screen displays a quantized value, wherein the reading of the quantized value consists of two values, namely an initial reading (usually the highest value) and a falling point ID, the initial reading and the falling point ID represent that the detected data is abnormal if the initial value is lower than a first threshold value and the falling point ID is larger than O, and the initial value represents that the detected data is severely abnormal if the initial value is lower than a second threshold value and the falling point ID is larger than O.
The aluminium system's medicine detects the tray, can realize the detection to the liquid medicine, when using the quantum to detect the therapeutic instrument in liquid medicine detection function, dismantle handheld electrode from the negative pole, replace the tray for medicine detection, namely the medicine detects the tray and connects on the negative pole of tester body, and the detector holds the insulating skin of probe and then presses the measured point of waiting to detect the liquid medicine with the top metal head of probe, makes the quantum detect between therapeutic instrument and the liquid medicine that waits to detect and constitutes the return circuit. The liquid medicine is the liquid medicine soaked in the cell tissue to be detected.
The principles of quantum resonance analysis are described in detail below. In the quantum detection therapeutic apparatus, a direct current of 1V is applied between two electrodes, and electrons and ions flow through a person to be detected or a liquid medicine under the action of the current. The movement of electrons is affected by two factors, namely cell metabolism and the change of the instant ion concentration in the liquid. From the closing of the circuit up to the final steady state, the effect is continuous and rapidly variable, described from a statistical physical point of view by a resistance function that varies with time, namely:
R(t)＝R 0 /[1-(1+t/τ 1 )exp(-t/τ 1 )]；
wherein R is a group. Indicating that after the circuit is closed, the electric circuit is processed by tau 1 Last steady state resistance reached later, τ 1 Is the relaxation time of electrons in current, realThe experiment shows that tau in general 1 <50ms。
In addition to electrical conduction, the cells will be polarized by the applied electric field E. The cell membrane will displace after being charged, thereby generating a reverse electric field. The positive and negative charges are slightly separated, so that each cell becomes a small electric dipole, and all electric dipoles are linearly arranged under the action of an applied voltage.
The electromagnetic wave continues through the potential space of the substance, which will be subjected to the action of S (t), calculated by the following integral:
the potential space is composed of a scalar part V and a vector partComposition is prepared.
According to the characteristic of standard change of quantum mechanics, the electromagnetic wave has phase difference in potential space:
in the above expression, i is an imaginary unit,is a plane constant, i.e., h/2 pi. When a beam of electron waves passes through the potential space of the substance, the phase of the beam of electron waves is adjusted, and characteristic information of the substance is transmitted at any time in the adjustment process.
When a beam of electromagnetic waves passes through the quantum detection therapeutic apparatus, the characteristics of the substance in the circuit are described as:
is the intrinsic amplitude determined by the driving voltage of the circuit, < >>Refers to the phase of the electron beam being adjusted. The presence or absence of the time phase depends on the substances in the circuit system, in this embodiment the person or liquid to be tested.
Electron beamThe vibration change is represented by the following state function:
representing the true amplitude +.>Representing its corresponding phase function. This expression is used to reflect the normal or abnormal physiological state of the object to be measured, that is, it can analyze the detection result and draw conclusions. When it describes a normal message, it represents that the distribution of electrons on the object to be measured is correct. Conversely, in an abnormal state, an error occurs in the electronic distribution.
In the above embodiment, only one of the detection of the liquid medicine and the detection of the human body may be selected, and in the following another embodiment, the detection of the liquid medicine and the detection of the human body may be implemented separately, and then the two detection results are subjected to the cross-correlation processing, thereby improving the accuracy of the detection results, which is specifically described as follows:
the detection signal of the human body is x (n) and the detection signal of the liquid medicine is y (n), and the cross-correlation function is defined as follows:
for signals x (n) and y (n) of finite length, the above summation can be solved. The cross-correlation function can reflect the similarity between the signal y (n) and the signal x (n) after shifting left by m sampling intervals, the greater the similarity, the greater the cross-correlation value, namely the higher the accuracy of the detection result is proved, and when the similarity is small, the cross-correlation value is also small, namely the lower the accuracy of the detection result is proved, and when the cross-correlation value is small, even zero.
Therefore, by calculating the correlation between the detection signal x (n) of the human body and the detection signal y (n) of the liquid medicine soaked in the relevant tissue cells, the accuracy of the detection result can be judged, and compared with the detection result of the human body or the detection result of the liquid medicine, the accuracy is greatly improved.
Equivalently, the components contained in the units, the assemblies, the mechanisms and the devices can be flexibly combined, so that the modular production can be performed according to actual needs, and the modular assembly is convenient. The above-mentioned components are only one embodiment of the present invention, and for convenience of reading, not limitation of the scope of protection of the present invention, so long as the above components are included and the same function should be understood as the equivalent technical solutions of the present invention.
In the present invention, unless expressly stated or limited otherwise, a first feature "up" or "down" a second feature may be the first and second features in direct contact, or the first and second features in indirect contact via an intervening medium. Moreover, a first feature being "above," "over" and "on" a second feature may be a first feature being directly above or obliquely above the second feature, or simply indicating that the first feature is level higher than the second feature. The first feature being "under", "below" and "beneath" the second feature may be the first feature being directly under or obliquely below the second feature, or simply indicating that the first feature is less level than the second feature.
It will be understood that when an element is referred to as being "mounted," "positioned," "secured" or "disposed" on another element, it can be directly on the other element or intervening elements may also be present. When an element is perpendicular or nearly perpendicular to another element, it is meant that the ideal conditions for both are perpendicular, but certain vertical errors may exist due to manufacturing and assembly effects. The terms "vertical," "horizontal," "left," "right," and the like are used herein for illustrative purposes only and are not meant to be the only embodiment.
The technical features of the above embodiments may be arbitrarily combined, and all possible combinations of the technical features in the above embodiments are not described for brevity of description, however, as long as there is no contradiction between the combinations of the technical features, they should be considered as the scope of the description.
The foregoing examples illustrate only a few embodiments of the invention, which are described in detail and are not to be construed as limiting the scope of the invention. It should be noted that it will be apparent to those skilled in the art that several variations and modifications can be made without departing from the spirit of the invention, which are all within the scope of the invention.
Claims (10)
1. A quantum detection therapeutic apparatus, comprising: the tester comprises a tester body, a test probe and a handheld electrode; the tester body comprises an anode, a cathode, a display screen, a singlechip processing module and a giant magnetoresistance sensing circuit;
direct current is applied between the positive electrode and the negative electrode, and the test probe is connected with the positive electrode of the tester body; the handheld electrode is detachably connected with the negative electrode of the tester body;
the giant magnetoresistance sensing circuit is used for preprocessing the signals detected by the test probes and outputting the signals as voltage signals;
the singlechip processing module is used for carrying out resonance action on the signal output by the giant magnetoresistance sensing circuit and a standard detection waveform code of a standard magnetic field wave corresponding to a detection item, analyzing a resonance signal, and obtaining a quantized value corresponding to the detection item based on three vectors of an electric field, a magnetic field and a force field and Fourier mathematical conversion;
the display screen displays the quantized values, the reading of the quantized values consists of two values, namely an initial reading and a falling point ID, wherein if the initial value is lower than a first threshold value and the falling point ID is larger than O, the abnormal detection data is represented, and if the initial value is lower than a second threshold value and the falling point ID is larger than O, the serious abnormal detection data is represented.
2. The quantum inspection therapeutic apparatus according to claim 1, further comprising a medicine inspection tray for holding a medicine liquid for immersing a cell tissue to be inspected; the medicine detection tray or the handheld electrode is detachably connected with the negative electrode of the tester body respectively.
3. The quantum detecting and treating apparatus according to claim 1, wherein the giant magnetoresistance sensing circuit is a wheatstone bridge using 4 giant magnetoresistance, R2 and R3 are sense resistors, and R1 and R4 are reference resistors.
4. The quantum dot detection therapeutic apparatus according to claim 1, wherein a direct current of 1V is applied between the positive electrode and the negative electrode.
5. The quantum detection therapeutic apparatus according to claim 2, wherein the single chip microcomputer processing module performs cross-correlation processing on detection signals of liquid medicine detection and human body detection, specifically:
the human body detection signal is x (n), the liquid medicine detection signal is y (n), and the cross correlation function r xy (m) is defined as follows:
cross correlation function r xy (m) reflecting the degree of similarity between the liquid medicine detection signal y (n) and the human body detection signal x (n) after shifting left by m sampling intervals, the more the degree of similarity isThe higher the accuracy of the detection result is, the smaller the similarity is, and the lower the accuracy of the detection result is.
6. The quantum inspection therapeutic apparatus of claim 1, wherein the test probe is wrapped with an insulating layer and the inner contact is made of brass or silver; the handheld electrode is of a tubular structure made of brass.
7. A quantum resonance analysis method using the quantum inspection therapeutic apparatus according to any one of claim 1 to 6, characterized in that,
when the human body is detected, the handheld electrode is connected to the negative electrode of the tester body, the handheld electrode is held by the hand of the detected person, and the detected point of the detected person is pressed by the top metal head of the test probe, so that a loop is formed between the quantum detection therapeutic instrument and the detected person;
inputting human body detection signals acquired by the test probes into the giant magneto-resistance sensing circuit, converting the human body detection signals into voltage signals and outputting the voltage signals to the singlechip processing module;
in the single chip microcomputer processing module, the signal output by the giant magneto-resistance sensing circuit and the standard detection waveform code of the standard magnetic field wave corresponding to the detection item are subjected to resonance action, resonance signals are analyzed, and quantized values corresponding to the detection item are obtained based on three-vector and Fourier mathematical conversion of an electric field, a magnetic field and a force field.
8. The method according to claim 7, wherein when the liquid medicine is detected, the drug detection tray is connected to the negative electrode of the tester body, and the tip metal head of the test probe is used to contact the detected point of the liquid medicine, so that a loop is formed between the quantum detection therapeutic instrument and the drug detection tray; and inputting the liquid medicine detection signals acquired through the test probes into the giant magneto-resistance sensing circuit, converting the liquid medicine detection signals into voltage signals and outputting the voltage signals to the singlechip processing module.
9. The method according to claim 8, wherein the liquid medicine detection and the human body detection are performed by a quantum detection therapeutic apparatus, respectively, and the two detection signals are subjected to a cross-correlation process, specifically:
the human body detection signal is x (n), the liquid medicine detection signal is y (n), and the cross correlation function r xy (m) is defined as follows:
cross correlation function r xy (m) reflects the similarity between the liquid medicine detection signal y (n) and the human body detection signal x (n) after shifting left by m sampling intervals, the greater the similarity is, the higher the accuracy of the detection result is, the smaller the similarity is, and the lower the accuracy of the detection result is.
10. The method according to claim 9, wherein the cross-correlation function r is set when the human body detection signal x (n) and the chemical liquid detection signal y (n) have no similarity xy The value of (m) is zero.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202110974731.6A CN113662528B (en) | 2021-08-24 | 2021-08-24 | Quantum detection therapeutic instrument and quantum resonance analysis method |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN202110974731.6A CN113662528B (en) | 2021-08-24 | 2021-08-24 | Quantum detection therapeutic instrument and quantum resonance analysis method |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| CN113662528A CN113662528A (en) | 2021-11-19 |
| CN113662528B true CN113662528B (en) | 2023-07-21 |
Family
ID=78545715
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN202110974731.6A Active CN113662528B (en) | 2021-08-24 | 2021-08-24 | Quantum detection therapeutic instrument and quantum resonance analysis method |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN113662528B (en) |
Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN2417829Y (en) * | 2000-04-24 | 2001-02-07 | 张海涛 | Quantum resonance detation instrument |
| KR20050107138A (en) * | 2004-05-07 | 2005-11-11 | 장용호 | Instrument and method for non-invasive in vivo testing for body fluid constituents using nmr |
| CN1951519A (en) * | 2005-10-21 | 2007-04-25 | 天年生物（中国）有限公司 | Quantum biological resonant mattress |
| CN109984744A (en) * | 2019-04-18 | 2019-07-09 | 河南爱怡家科技有限公司 | A kind of somatic data acquisition and analysis method based on quantizing resonance |
| WO2019207815A1 (en) * | 2018-04-24 | 2019-10-31 | 国立大学法人大阪大学 | Method for enhancing magnetic resonance sensitivity by quantum coding |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP4509336B2 (en) * | 2000-08-31 | 2010-07-21 | 株式会社東芝 | Magnetic resonance equipment |
| CN1498596A (en) * | 2002-11-11 | 2004-05-26 | 释延豹 | Method and device for testing human health status based on principle of quantum resonance |
| EP2207571A4 (en) * | 2007-05-02 | 2011-11-23 | Derek D Feng | Quantum theory-based continuous precision nmr/mri: method and apparatus |
| DE102009041642A1 (en) * | 2009-09-17 | 2011-03-31 | Ohnesorge, Frank, Dr. | Quantum wire array field effect (power) transistor QFET (especially magnetic - MQFET, but also electrically or optically driven) at room temperature, based on polyacetylene-like molecules |
| KR101310750B1 (en) * | 2012-01-31 | 2013-09-24 | 한국표준과학연구원 | biomagnetic resonance apparatus and the measuring method of the same |
-
2021
- 2021-08-24 CN CN202110974731.6A patent/CN113662528B/en active Active
Patent Citations (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN2417829Y (en) * | 2000-04-24 | 2001-02-07 | 张海涛 | Quantum resonance detation instrument |
| KR20050107138A (en) * | 2004-05-07 | 2005-11-11 | 장용호 | Instrument and method for non-invasive in vivo testing for body fluid constituents using nmr |
| CN1951519A (en) * | 2005-10-21 | 2007-04-25 | 天年生物（中国）有限公司 | Quantum biological resonant mattress |
| WO2019207815A1 (en) * | 2018-04-24 | 2019-10-31 | 国立大学法人大阪大学 | Method for enhancing magnetic resonance sensitivity by quantum coding |
| CN109984744A (en) * | 2019-04-18 | 2019-07-09 | 河南爱怡家科技有限公司 | A kind of somatic data acquisition and analysis method based on quantizing resonance |
Non-Patent Citations (1)
| Title |
|---|
| 非线性响应对巨磁阻的影响;陈红霞, 曾祥华, 毕桥;原子与分子物理学报(第02期);第241-244页 * |
Also Published As
| Publication number | Publication date |
|---|---|
| CN113662528A (en) | 2021-11-19 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Bera | Applications of electrical impedance tomography (EIT): a short review | |
| US6397095B1 (en) | Magnetic resonance—electrical impedance tomography | |
| US5978694A (en) | Method and apparatus for detecting a magnetically responsive substance | |
| US8483795B2 (en) | Primary source mirror for biomagnetometry | |
| Chopin et al. | Magnetoresistive sensor in two-dimension on a 25 μm thick silicon substrate for in vivo neuronal measurements | |
| Roth | Biomagnetism: the first sixty years | |
| Kanoun | Impedance spectroscopy advances and future trends: A comprehensive review | |
| CN113662528B (en) | Quantum detection therapeutic instrument and quantum resonance analysis method | |
| Kumar et al. | Recent prospects of medical imaging and sensing technologies based on electrical impedance data acquisition system | |
| CN203815454U (en) | Body surface conductivity distribution tester | |
| CN103860172B (en) | Body surface conductance distribution detector | |
| Luaibi et al. | Noninvasive blood glucose level measurement using nuclear magnetic resonance | |
| CN107205699A (en) | Application for non-invasively checking at least apparatus and method of the part of blood constituent and device | |
| CN111896586A (en) | Blood glucose monitoring sensor testing method and testing device | |
| Cerny et al. | Design and implementation of textile sensors for biotelemetry applications | |
| JPH07318600A (en) | Non-contact conductivity measuring instrument | |
| Trigona et al. | RTD-Fluxgate magnetometers for detecting iron accumulation in the brain | |
| Chen et al. | Planar MIT sensor array with gradiometers for local hemorrhage detection | |
| Wikswo Jr | High-resolution magnetic imaging: Cellular action currents and other applications | |
| CN113598778A (en) | Human body data detection and analysis method based on quantum resonance | |
| Neronov et al. | Development of an NMR relaxometer for determining magnetization dynamics of water protons in living tissues and its use for evaluating age-related changes | |
| Malmivuo et al. | A new practical lead system for vector magnetocardiography | |
| Jette et al. | SQUID magnetometry applied as a non-invasive electroanalytic chemical technique | |
| Penhaker et al. | Sensitivity analysis in sensor homecare implementation | |
| CN217338566U (en) | Device for evaluating influence of different external substances on detection value by meridian detector |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PB01 | Publication | ||
| PB01 | Publication | ||
| SE01 | Entry into force of request for substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| GR01 | Patent grant | ||
| GR01 | Patent grant |